<DOC>
	<DOCNO>NCT01316328</DOCNO>
	<brief_summary>The single shot partial breast irradiation ( SSPBI ) trial design prospective Phase II `` single-arm study '' . The use single dose tumor bed expected effective term tumor control , could increase incidence radiation induce erythema . Therefore , investigator assume decreased DNA repair capability , well reduce detoxification damage cause oxidative stress could explain increased acute toxicity , i.e . high incidence erythema single dose . For reason investigator decide investigate SNPs gene involve antioxidant DNA damage repair pathway GST , XRCC1 , XRCC3 RAD51 . The investigator assume erythema rate 20 % 54 % patient group low high risk , respectively , ( group identify base absence/presence polymorphism alone combination ) , thus minimum sample size 56 patient α=0.05 , 2-tailed test power study 80 % .</brief_summary>
	<brief_title>Determination Predictive Genetic Markers Toxicity After Hypofractionated Radiotherapy Breast Cancer Patients Post-Conservative Surgery</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Age ≥ 48 year old life expectancy least 5 year Postmenopausal status Histologically proven , non lobular , adenocarcinoma breast Primary tumours ≤ 3 cm Negative surgical margin ( ≥ 2 mm ) Negative sentinel node &lt; 4 positive axillary node No extracapsular extension No previous radiotherapy multicentric disease extend intraductal component ( EIC &gt; 25 % ) Paget 's disease lobular adenocarcinoma distant metastases All criterion allow identify patient low risk local recurrence .</criteria>
	<gender>Female</gender>
	<minimum_age>48 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>toxicity single shot partial breast irradiation ( SSPBI )</keyword>
</DOC>